News & Events

Recently, the GENEYE® System medical device (Model: GCP-30) from SuZhou GenDx Biotech CO., LTD. has successfully obtained the Medical Device Product Certification from Thailand (Certificate No.: 68-2-3-1-0012263), officially securing compliance access to the Southeast Asian medical market. This achievement accelerates the company's global expansion in precision medicine!

The certification covers the entire GENEYE® System equipment, which was jointly advanced for implementation with BCC Medical Group Co., Ltd. as the certificate holder. This milestone not only signifies that the GENEYE® System has received authoritative recognition from Thai authorities for its technical performance, safety, and compliance but also, with its precise detection capabilities and stable system performance, injects innovative momentum into local clinical diagnosis and precision medicine applications.

Southeast Asia, as one of the fastest-growing regions in the global healthcare industry, boasts a large population and continuously rising demand for precision medicine technologies. The acquisition of this certification not only further opens market access for GenDx in multiple Southeast Asian countries but also enables the company to leverage the technical advantages of the GENEYE® System to provide more accurate diagnostic solutions for local patients, thereby helping to elevate regional medical service standards. This achievement serves as strong validation of GenDx's technological R&D capabilities and lays a solid compliance foundation for the company's future expansion into other emerging global markets.

Moving forward, GenDx will take this market access in Thailand as a new starting point, continuously deepen technological innovation and global in the field of precision medicine, accelerate the entry of more cutting-edge products into international markets, and ensure that advanced diagnostic technologies benefit more patients worldwide, writing a new chapter in the company's global development.